Feature | August 06, 2014

Medtronic, Acist Enter Agreement to Commercialize Next Generation FFR-IVUS Technologies

Collaboration provides increased commercial reach, brand synergies and customer access to new technologies

Medtronic, Acist Agreement FFR-IVUS Technologies

August 6, 2014  — Acist Medical Systems announced it entered into a strategic agreement with Medtronic to co-promote the world’s first Rapid Exchange FFR (RXi) and high definition IVUS (HDi) technologies in the United States. Under this agreement, Acist and Medtronic will work collaboratively to introduce these groundbreaking products into cardiac catheterization laboratories across the United States.

Fractional flow reserve (FFR) has quickly become the standard that interventional cardiologists use to determine which patients can most benefit from stenting. Intravascular ultrasound (IVUS) is an advanced diagnostic modality that provides greater insight into arterial disease than standard angiography alone. The Acist RXi and HDi systems are quicker, easier to use and offer detailed insight that physicians can use to optimize treatment choice for their patients.

Through this collaboration, Acist and Medtronic will bring this technology to existing and new customers who value improved modalities that simplify procedures and benefit their patients.

Acist’s new Rapid FFR system, which utilizes the ultra-thin Acist Navvus Rapid Exchange MicroCatheter and RXi console, was introduced earlier this year in the United States and Europe. The Navvus MicroCatheter can be used over a standard 0.014-inch guidewire, and the RXi system facilitates rapid FFR assessments before, during and post-intervention. This technology is the first of its kind, providing the reassurance of accurate and reliable FFR measurements and the advantages of Rapid Exchange technology.

This agreement makes Acist/Medtronic the forth vendor for FFR and IVUS systems in the U.S. market.

For more information: www.acist.com, www.bracco.com, www.medtronic.com

Related Content

Sponsored Content | Videos | Cath Lab| March 28, 2017
MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017 Americ
Philips Azurion angiography system, FFR for STEMI
Feature | Cath Lab| March 27, 2017
March 27, 2017 — Patients experiencing a major heart attack often have more than one clogged artery, but under curren
Philips, cardiology solutions, ACC.17, Azurion angiography system, iFR outcomes results, IntelliSpace Cardiovascular
News | Cardiac Imaging| March 24, 2017
At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips showcased a broad...
Sponsored Content | Videos | FFR Catheters| March 23, 2017
Justin Davies, MBBS, of Imperial College London, and Matthias Götberg, M.D, Ph.D., of Skane University Hospital, deta
iFR, iFR vs. FFR, ACC late breaking trial, iFR-SWEDEHEART, DEFINE-FLAIR, Justin E. Davies,

Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions. 

Feature | FFR Catheters| March 20, 2017
March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR)
HeartFlow FFRct Analysis, NICE guidance, U.K., United Kingdom, guidelines, stable chest pain
News | CT Angiography (CTA)| February 14, 2017
The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued guidance for use of...
ACIST-FFR Study, enrollment complete, Navvus catheter, fractional flow reserve
News | FFR Catheters| January 12, 2017
Acist Medical Systems Inc. announced that enrollment is complete for its Fractional Flow Reserve (FFR) Study –...
Sponsored Content | Videos | TCT| November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies
COLOR trial, TCT, NIRS, stenting vulnerable plaques, near infrared spectroscopy

An intravascular ultrasound image (IVUS) with co-registered NIRS showing yellow for the detection of lipid rich plaque in a coronary artery. 

News | Cath Lab| November 07, 2016
November 7, 2016 – Two-year results from the COLOR Trial, the first large-scale multicenter prospective study of its
Philips, TCT 2016, image guidance technologies, iFR, HeartNavigator
News | Cath Lab| October 26, 2016
Philips recently announced its latest image guidance solutions to be featured at the 2016 Transcatheter Cardiovascular...
Overlay Init